Loading
Maurice van den Bosch represents Netherlands Cancer Institute (NKI-AvL) in the Organisation of European Cancer Institutes, which lists the centre among its members in The Netherlands.
Maurice van den Bosch is listed by the Organisation of European Cancer Institutes (OECI) as the representative of Netherlands Cancer Institute (NKI-AvL), its full member in The Netherlands. OnCo records the name from the OECI membership list so that the centre's page names its contact within Europe's cancer-centre network; the person's clinical or management role is not stated by the list and should be checked at the institution's website.
| Title | Journal | Year |
|---|---|---|
| Oral Contraceptives and the Risk of Myocardial Infarction | New England Journal of Medicine | 2001 |
| Preoperative MRI and surgical management in patients with nonpalpable breast cancer: The MONET – Randomised controlled trial | European Journal of Cancer | 2010 |
| Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study | Stroke | 2002 |
These papers come from the OpenAlex author record for this person at their institution, taking the most cited articles with a DOI.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.
Shares Organisation of European Cancer Institutes and the tags oeci-representative, leader.